Department of Surgery, Institute for Critical Care Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Department of Medicine, Division of Critical Care Medicine, Cooper University Hospital, Camden, NJ.
Am J Infect Control. 2020 Apr;48(4):460-464. doi: 10.1016/j.ajic.2019.08.019. Epub 2019 Oct 8.
This study describes the role of a novel vascular access service in the reduction and prevention of central line-associated bloodstream infections (CLABSIs). We conducted a retrospective analysis of data obtained over a span of 24 months after implementation of our vascular access service. We identified a progressive decline in the CLABSI rate and standardized infection ratio (SIR) in 2017 (rate, 1.75; SIR, 1.25) and in 2018 (rate, 1.037; SIR, 0.91). The reduction in CLABSIs was attributed to appropriate triage, insertion, and maintenance of vascular access devices.
本研究描述了一种新型血管通路服务在降低和预防中心静脉导管相关血流感染（CLABSI）方面的作用。我们对血管通路服务实施后 24 个月的数据进行了回顾性分析。我们发现 2017 年（发生率为 1.75；感染率标准化比值（SIR）为 1.25）和 2018 年（发生率为 1.037；SIR 为 0.91）的 CLABSI 发生率和 SIR 呈逐渐下降趋势。CLABSI 的减少归因于对血管通路装置的适当分诊、插入和维护。
